Rucaparib (Rubraca) - Oncology Nurse Advisor
Skip to navigation Skip to main content

Rucaparib (Rubraca)

Slideshow

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

This slideshow reviews rucaparib (Rubraca), indicated for the treatment of deleterious BRCA mutation (germline and/or somatic) associated with advanced ovarian cancer who have been treated with 2 or more chemotherapies.

Table of Contents

Slide 4: Dosage and Administration
Slide 10: Cautions, Effects, and Interactions
Slide 17: What to Tell Your Patient
Slide 26: Reference

Topics:

Drug Information Slideshows Stat Consult
Next hm-slideshow in Slides